Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients

NCT00157157

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix, Arizona, United States
  • Little Rock, Arkansas, United States
  • Los Angeles, California, United States
  • Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Completed

A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

NCT02418793

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View Trial Details
Completed

Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)

NCT01736475

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • University of Florida, College of Medicine Gainesville, Florida, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 72 locations
View Trial Details
Completed

Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

NCT00243386

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Los Angeles, California, United States
  • Chicago, Illinois, United States
  • Indianapolis, Indiana, United States
  • Minneapolis, Minnesota, United States
View all 29 locations
View Trial Details
Completed

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

NCT00357656

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Los Angeles Orthopaedic Hospital Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Rush Presbyterian St. Lukes Chicago, Illinois, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
View all 36 locations
View Trial Details
Completed

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

NCT00851721

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Chicago, Illinois, United States
  • Cleveland, Ohio, United States
  • Rio de Janeiro, Brazil
  • São Paulo, Brazil
View all 17 locations
View Trial Details
Completed

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

NCT01178294

Conditions
Acquired Hemophilia A, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +8 more
Locations
  • Indiana Hemophilia and Thrombosis Center Indianapolis, Indiana, United States
  • Louisiana Center for Bleeding & Clotting Disorders New Orleans, Louisiana, United States
  • National Institutes of Health - Warren G. Magnuson Clinical Center Bethesda, Maryland, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions